Indefinite Delivery Contract 75N91023D00009
Award Date
4/11/23
Last Date to Order
4/10/28
Federal Agency
National Cancer Institute
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Cancer Institute awarded Sri International a multiple award indefinite delivery contract to provide research and development services supporting preclinical pharmacokinetic and pharmacology evaluations of agents for cancer patients. The contract has a potential value of $9.9 million and a period of performance through September 2028. Under the contract, Sri International will implement and validate analytical methodologies to quantify compounds from biological fluids and tissues...
This federal contract IDV award is for CRO (Contract Research Organization) support for medicinal chemistry lead optimization programs managed by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The prime contractor, SRI International, is a large non-profit research and development organization with a significant history of providing advanced scientific and technical...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...
This federal contract IDV was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The IDV has a ceiling value of $20,011,859 and does not have any set-aside designations. It provides a vehicle for NICHD to efficiently procure a wide range of scientific, engineering, and technical services from SRI International,...
This single-award IDV was issued by the National Cancer Institute, part of the Department of Health and Human Services, on April 11, 2023 with a potential value of $12.1 million. The contract aims to procure analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations to support the Institute's research efforts. Research Triangle Institute was selected as the prime contractor to deliver the required products and services over a five-year ordering period ending April 10,...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the non-profit research institute SRI International. The $12.9 million contract, awarded on September 30, 2015 with a period of performance through November 30, 2020, aims to support "Biomarker Characterization and Confirmation for Rapid Clinical Diagnosis of Select Biothreat Agents." As the prime contractor,...
The federal contract IDV award is a $499,868 Other Transaction IDV awarded by the Defense Advanced Research Projects Agency (DARPA) to SRI International, a non-profit research and development institute. The contract, titled "EQUIP-A-PHARMA - PHASE 1", does not have a small business set-aside. SRI International, an established provider of scientific, engineering, and technical services to federal agencies, will deliver research and development in support of DARPA's mission. The contract...
The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has awarded a Basic Ordering Agreement (BOA) contract to Sri International, a nonprofit research and development institute. The purpose of this $9.75 million, single-award IDV contract is to conduct toxicological evaluations of potential medications to support NIDA's drug abuse research program. Under this IDV, NIDA has issued several cost-plus-fixed-fee task orders to Sri International, valued at...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays. Under this IDC, IITRI provides a range of preclinical research...